BioCorRx (BICX) Non Operating Income (2010 - 2026)
BioCorRx (BICX) reported Non Operating Income of $96,108 for Q1 2026, up 11.5% from $86,182 a year earlier and up 52.6% from the prior quarter.
Powered by 
Analysis
BioCorRx (BICX) Non Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, BioCorRx's Non Operating Income came in at $1.33 million, up 402.3% year-over-year; for FY2025, it came in at $1.32 million.
- Non Operating Income has a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
- By year, Non Operating Income came in at -$89,597 in FY2024, $17,306 in FY2023 (-94.6%), $321,163 in FY2022 (+7.2%) and $299,469 in FY2021 (-92.5%).
- Five-year quarterly Non Operating Income spans a low of -$268,771 in Q1 2024 and a high of $1.14 million in Q3 2025.
- Year over year, Non Operating Income gained in four of the last five quarters, with growth averaging 229.7%.
- The high point for year-over-year Non Operating Income in five years was Q3 2025 (growth of 675.1%); the low point was Q4 2021 (a decline of 84.8%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $62,967 (Q4 2025), $1.14 million (Q3 2025) and $36,644 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | BioCorRx | 830.00 | -906,148.00 | -56,997.00 | 463,832.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 463,832.00 |
| Mar 31, 2026 | 96,108.00 |
| Dec 31, 2025 | 62,967.00 |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 36,644.00 |
| Mar 31, 2025 | 86,182.00 |
| Dec 31, 2024 | -102,893.00 |
| Sep 30, 2024 | 146,711.00 |
| Jun 30, 2024 | 135,356.00 |
| Mar 31, 2024 | -268,771.00 |
| Dec 31, 2023 | -146,297.00 |
| Sep 30, 2023 | 94,520.00 |
| Jun 30, 2023 | 23,354.00 |
| Mar 31, 2023 | 45,729.00 |
| Dec 31, 2022 | 22,821.00 |
| Sep 30, 2022 | 78,122.00 |
| Jun 30, 2022 | 40,537.00 |
| Mar 31, 2022 | 179,683.00 |
| Dec 31, 2021 | 131,403.00 |
| Sep 30, 2021 | 271,412.00 |
API Access
BioCorRx Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();